Autonomic dysfunction in cirrhosis and portal hypertension

References

• Iga A., Nomura M., Sawada Y., Ito S., Nakaya Y. Autonomic nervous dysfunction in patients with liver cirrhosis using 123I‐metaiodobenzylguanidine myocardial scintigraphy and spectrum analysis of heart‐rate variability. J Gastroenterol Hepatol 2003; 18: 651–9
   PubMed Web of Science ®Google Scholar
• Hendrickse M. T., Triger D. R. Autonomic dysfunction in chronic liver disease. Clin Auton Res 1993; 3: 227–31
   PubMedGoogle Scholar
• Chaudhry V., Corse A. M., O'Brian R., Cornblath D. R., Klein A. S., Thuluvath P. J. Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology 1999; 29: 1698–703
   PubMed Web of Science ®Google Scholar
• Moller S., Henriksen J. H. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9–15
   PubMed Web of Science ®Google Scholar
• Trevisani F., Sica G., Bernardi M. Autonomic neuropathy in advanced liver disease. Hepatology 1996; 24: 1549
   PubMed Web of Science ®Google Scholar
• Gumurdulu Y., Yapar Z., Canataroglu A., Serin E., Gumurdulu D., Kibar M., et al. Gastric emptying time and the effect of cisapride in cirrhotic patients with autonomic neuropathy. J Clin Gastroenterol 2003; 36: 175–8
   PubMed Web of Science ®Google Scholar
• Fleckenstein J. F., Frank S., Thuluvath P. J. Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 1996; 23: 471–5
   PubMed Web of Science ®Google Scholar
• Frokjaer V. G., Strauss G. I., Mehlsen J., Knudsen G. M., Rasmussen V., Larsen F. S. Autonomic dysfunction and impaired cerebral autoregulation in cirrhosis. Clin Auton Res 2006; 16: 208–16
   PubMed Web of Science ®Google Scholar
• Lagi A., La V. G., Barletta G., Cencetti S., Bacalli S., Cipriani M., et al. Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study. J Hepatol 1997; 27: 114–20
   PubMed Web of Science ®Google Scholar
• Strauss G. I., Hansen B. A., Herzog T., Larsen F. S. Cerebral autoregulation in patients with end‐stage liver disease. Eur J Gastroenterol Hepatol 2000; 12: 767–71
   PubMed Web of Science ®Google Scholar
• Hendrickse M. T., Thuluvath P. J., Triger D. R. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992; 339: 1462–4
   PubMed Web of Science ®Google Scholar
• Mohamed R., Forsey P. R., Davies M. K., Neuberger J. M. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end‐stage liver disease. Hepatology 1996; 23: 1128–34
   PubMed Web of Science ®Google Scholar
• Perez‐Pena J., Rincon D., Banares R., Olmedilla L., Garutti I., Grigorov I., et al. Autonomic neuropathy in end‐stage cirrhotic patients and evolution after liver transplantation. Transpl Proc 2003; 35: 1834–5
   PubMed Web of Science ®Google Scholar
• Furness J. B. The organisation of the autonomic nervous system: peripheral connections. Auton Neurosci 2006; 130: 1–5
   PubMed Web of Science ®Google Scholar
• Ropper A. H., Brown R. H. Disorders of the autonomic nervous system, respiration, and swallowing. Adams and Victor's principles of neurology, 8th edn, A. H Ropper, R. H Brown. McGraw‐Hill, New York 2005
   Google Scholar
• Low P. A. Autonomic nervous system function. J Clin Neurophysiol 1993; 10: 14–27
   PubMed Web of Science ®Google Scholar
• Dillon J. F., Plevris J. N., Nolan J., Ewing D. J., Neilson J. M., Bouchier I. A., et al. Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24‐hour heart rate variability. Am J Gastroenterol 1994; 89: 1544–7
   PubMed Web of Science ®Google Scholar
• Hendrickse M. T., Triger D. R. Peripheral and cardiovascular autonomic impairment in chronic liver disease: prevalence and relation to hepatic function. J Hepatol 1992; 16: 177–83
   PubMed Web of Science ®Google Scholar
• Ewing D. J., Clarke B. F. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982; 285: 916–18
   PubMed Web of Science ®Google Scholar
• Oliver M. I., Miralles R., Rubies‐Prat J., Navarro X., Espadaler J. M., Sola R., et al. Autonomic dysfunction in patients with non‐alcoholic chronic liver disease. J Hepatol 1997; 26: 1242–8
   PubMed Web of Science ®Google Scholar
• Newton J. L., Davidson A., Kerr S., Bhala N., Pairman J., Burt J., et al. Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity. Eur J Gastroenterol Hepatol 2007; 19: 125–32
   PubMed Web of Science ®Google Scholar
• Dillon J. F., Nolan J., Thomas H., Williams B. C., Neilson J. M., Bouchier I. A., et al. The correction of autonomic dysfunction in cirrhosis by captopril. J Hepatol 1997; 26: 331–5
   PubMed Web of Science ®Google Scholar
• Laffi G., Lagi A., Cipriani M., Barletta G., Bernardi L., Fattorini L., et al. Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. Hepatology 1996; 24: 1063–7
   PubMed Web of Science ®Google Scholar
• Fleisher L. A., Fleckenstein J. F., Frank S. M., Thuluvath P. J. Heart rate variability as a predictor of autonomic dysfunction in patients awaiting liver transplantation. Dig Dis Sci 2000; 45: 340–4
   PubMed Web of Science ®Google Scholar
• Ates F., Topal E., Kosar F., Karincaoglu M., Yildirim B., Aksoy Y., et al. The relationship of heart rate variability with severity and prognosis of cirrhosis. Dig Dis Sci 2006; 51: 1614–18
   PubMed Web of Science ®Google Scholar
• Gentile S., Marmo R., Peduto A., Montella F., Coltorti M. Autonomic neuropathy in liver cirrhosis: relationship with alcoholic aetiology and severity of the disease. Ital J Gastroenterol 1994; 26: 53–8
   PubMedGoogle Scholar
• Decaux G., Cauchie P., Soupart A., Kruger M., Delwiche F. Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis. Br Med J (Clin Res Ed) 1986; 293: 1534–6
   PubMed Web of Science ®Google Scholar
• Kempler P., Varadi A., Szalay F., Oravecz L., Kadar E., Kiss E. [Autonomic neuropathy in chronic liver diseases]. Gastroenterol J 1990; 50: 187–9
   PubMedGoogle Scholar
• Hendrickse M. T., Triger D. R. Autonomic and peripheral neuropathy in primary biliary cirrhosis. J Hepatol 1993; 19: 401–7
   PubMed Web of Science ®Google Scholar
• Thuluvath P. J., Triger D. R. Autonomic neuropathy and chronic liver disease. Q J Med 1989; 72: 737–47
   PubMedGoogle Scholar
• Macgilchrist A. J., Reid J. L. Impairment of autonomic reflexes in cirrhosis. Am J Gastroenterol 1990; 85: 288–92
   PubMed Web of Science ®Google Scholar
• Barter F., Tanner A. R. Autonomic neuropathy in an alcoholic population. Postgrad Med J 1987; 63: 1033–6
   PubMed Web of Science ®Google Scholar
• Pfeifer M. A., Weinberg C. R., Cook D. L., Reenan A., Halar E., Halter J. B., et al. Correlations among autonomic, sensory, and motor neural function tests in untreated non‐insulin‐dependent diabetic individuals. Diabetes Care 1985; 8: 576–84
   PubMed Web of Science ®Google Scholar
• Bernardi M., Di M. C., Trevisani F., Fornale L., Andreone P., Cursaro C., et al. Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology 1993; 105: 188–93
   PubMed Web of Science ®Google Scholar
• McCullough A. J., Mullen K. D., Kalhan S. C. Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991; 14: 1102–11
   PubMed Web of Science ®Google Scholar
• Iwao T., Toyonaga A., Sato M., Oho K., Sakai T., Tayama C., et al. Effect of posture‐induced blood volume expansion on systemic and regional hemodynamics in patients with cirrhosis. J Hepatol 1997; 27: 484–91
   PubMed Web of Science ®Google Scholar
• Heine G. H., Sester U., Kohler H. [Volume retention in heart failure, nephrotic syndrome, and liver cirrhosis.]. Internist (Berl) 2006; 47: 1136–44
   PubMed Web of Science ®Google Scholar
• Wiest R., Jurzik L., Herold T., Straub R. H., Scholmerich J. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension. Peptides 2007; 28: 396–404
   PubMed Web of Science ®Google Scholar
• Moller S., Henriksen J. H. The systemic circulation in cirrhosis. Ascites and renal dysfunction in liver disease, 2nd edn, P Gines, V Arroyo, J Rodes, R. W Schrier. Blackwell, Malden 2005; 139–55
   Google Scholar
• Niederberger M., Gines P., Martin P. Y., Tsai P., Morris K., McMurtry I., et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 1996; 24: 947–51
   PubMed Web of Science ®Google Scholar
• Rockey D. C., Chung J. J. Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis. Am J Physiol 1997; 273: G124–30
   PubMed Web of Science ®Google Scholar
• Guarner C., Soriano G., Tomas A., Bulbena O., Novella M. T., Balanzo J., et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139–43
   PubMed Web of Science ®Google Scholar
• Laffi G., Foschi M., Masini E., Simoni A., Mugnai L., La V. G., et al. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995; 22: 1666–73
   PubMed Web of Science ®Google Scholar
• Rasaratnam B., Connelly N., Chin‐Dusting J. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?. Clin Sci (Lond) 2004; 107: 425–34
   PubMed Web of Science ®Google Scholar
• Blei A. T. The pathophysiology of brain edema in acute liver failure. Neurochem Int 2005; 47: 71–7
   PubMed Web of Science ®Google Scholar
• Arguedas M. R., Abrams G. A., Krowka M. J., Fallon M. B. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003; 37: 192–7
   PubMed Web of Science ®Google Scholar
• Munoz J., Albillos A., Perez‐Paramo M., Rossi I., Varez‐Mon M. Factors mediating the hemodynamic effects of tumor necrosis factor‐alpha in portal hypertensive rats. Am J Physiol 1999; 276: G687–93
   PubMedGoogle Scholar
• Iwakiri Y., Groszmann R. J. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006; 43: S121–31
   PubMed Web of Science ®Google Scholar
• Wagner J. A., Varga K., Ellis E. F., Rzigalinski B. A., Martin B. R., Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 1997; 390: 518–21
   PubMed Web of Science ®Google Scholar
• Batkai S., Jarai Z., Wagner J. A., Goparaju S. K., Varga K., Liu J., et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001; 7: 827–32
   PubMed Web of Science ®Google Scholar
• Ros J., Claria J., To‐Figueras J., Planaguma A., Cejudo‐Martin P., Fernandez‐Varo G., et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 2002; 122: 85–93
   PubMed Web of Science ®Google Scholar
• Chu C. J., Lee F. Y., Chang F. Y., Wang S. S., Lin H. C., Wu S. L., et al. Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor‐alpha. Zhonghua Yi Xue Za Zhi (Taipei) 1997; 59: 145–50
   PubMedGoogle Scholar
• Yang Y. Y., Lin H. C., Huang Y. T., Lee T. Y., Lee W. C., Hou M. C., et al. Adaptive vasodilatory response after octreotide treatment. Am J Physiol Gastrointest Liver Physiol 2001; 281: G117–23
   PubMed Web of Science ®Google Scholar
• Hosoki R., Matsuki N., Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527–31
   PubMed Web of Science ®Google Scholar
• Zhao W., Wang R. H(2)S‐induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 2002; 283: H474–80
   PubMed Web of Science ®Google Scholar
• Cheng Y., Ndisang J. F., Tang G., Cao K., Wang R. Hydrogen sulfide‐induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 2004; 287: H2316–23
   PubMed Web of Science ®Google Scholar
• Iwakiri Y., Groszmann R. J. Vascular endothelial dysfunction in cirrhosis. J Hepatol 2007; 46: 927–34
   PubMed Web of Science ®Google Scholar
• Bendtsen F., Schifter S., Henriksen J. H. Increased circulating calcitonin gene‐related peptide (CGRP) in cirrhosis. J Hepatol 1991; 12: 118–23
   PubMed Web of Science ®Google Scholar
• Gupta S., Morgan T. R., Gordan G. S. Calcitonin gene‐related peptide in hepatorenal syndrome. A possible mediator of peripheral vasodilation?. J Clin Gastroenterol 1992; 14: 122–6
   PubMed Web of Science ®Google Scholar
• Schrier R. W., Niederberger M., Weigert A., Gines P. Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis. Semin Liver Dis 1994; 14: 14–22
   PubMed Web of Science ®Google Scholar
• Sieber C. C., Lopez‐Talavera J. C., Groszmann R. J. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750–4
   PubMed Web of Science ®Google Scholar
• Sogni P., Sabry S., Moreau R., Gadano A., Lebrec D., nh‐Xuan A. T. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J Hepatol 1996; 24: 487–90
   PubMed Web of Science ®Google Scholar
• Bernardi M., Trevisani F., Santini C., Zoli G., Baraldini M., Ligabue A., et al. Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. Hepatology 1983; 3: 56–64
   PubMed Web of Science ®Google Scholar
• Jimenez W., Rodes J. Impaired responsiveness to endogenous vasoconstrictors and endothelium‐derived vasoactive factors in cirrhosis. Gastroenterology 1994; 107: 1201–3
   PubMed Web of Science ®Google Scholar
• Salo J., Gines A., Quer J. C., Fernandez‐Esparrach G., Guevara M., Gines P., et al. Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. J Hepatol 1996; 25: 916–23
   PubMed Web of Science ®Google Scholar
• Lee S. S., Sharkey K. A. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats. Am J Physiol 1993; 264: G868–73
   PubMed Web of Science ®Google Scholar
• Mailman D. A role for abdominal vagal afferents in lipopolysaccharide‐induced hypotension. Shock 2002; 18: 177–81
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Moller S., Schifter S., Abrahamsen J., Becker U. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems. Gut 2001; 49: 112–18
   PubMed Web of Science ®Google Scholar
• Henriksen J. H., Fuglsang S., Bendtsen F., Christensen E., Moller S. Arterial compliance in patients with cirrhosis: stroke volume‐pulse pressure ratio as simplified index. Am J Physiol Gastrointest Liver Physiol 2001; 280: G584–94
   PubMed Web of Science ®Google Scholar
• Rowell L. B. Human cardiovascular control. Oxford University Press, Oxford 1993
   Google Scholar
• Moller S., Wiinberg N., Hernriksen J. H. Noninvasive 24‐hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995; 22: 88–95
   PubMed Web of Science ®Google Scholar
• Moller S., Henriksen J. H., Bendtsen F. Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender. Am J Physiol Gastrointest Liver Physiol 2003; 284: G970–9
   PubMed Web of Science ®Google Scholar
• Moller S., Norgaard A., Henriksen J. H., Frandsen E., Bendtsen F. Effects of tilting on central hemodynamics and homeostatic mechanisms in cirrhosis. Hepatology 2004; 40: 811–19
   PubMed Web of Science ®Google Scholar
• Dudley F. J., Esler M. D. The sympathetic nervous system in cirrhosis. Ascites and renal dysfunction in liver disease, P Gines, V Arroyo, J Rodes, R. W Schrier. Blackwell, Malden 2005; 54–72
   Google Scholar
• Moller S., Iversen J. S., Henriksen J. H., Bendtsen F. Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems. Am J Physiol Heart Circ Physiol 2007; 292: H2966–72
   PubMed Web of Science ®Google Scholar
• La V. G., Barletta G., Romanelli R. G., Laffi G., Del B. R., Vizzutti F., et al. Cardiovascular effects of canrenone in patients with preascitic cirrhosis. Hepatology 2002; 35: 1441–8
   PubMed Web of Science ®Google Scholar
• Struthers A. D. Aldosterone blockade in cardiovascular disease. Heart 2004; 90: 1229–34
   PubMed Web of Science ®Google Scholar
• Wong F., Liu P., Lilly L., Bomzon A., Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci (Lond) 1999; 97: 259–67
   PubMed Web of Science ®Google Scholar
• Moller S., Henriksen J. H. Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy. Scand J Gastroenterol 2001; 36: 785–94
   PubMed Web of Science ®Google Scholar
• Liu H., Song D., Lee S. S. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002; 26: 842–7
   PubMedGoogle Scholar
• Pateron D., Beyne P., Laperche T., Logeard D., Lefilliatre P., Sogni P., et al. Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 1999; 29: 640–3
   PubMed Web of Science ®Google Scholar
• Mohamed R., Forsey P. R., Davies M. K., Neuberger J. M. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end‐stage liver disease. Hepatology 1996; 23: 1128–34
   PubMed Web of Science ®Google Scholar
• Moller S., Krag A., Henriksen J. H., Bendtsen F. Pathophysiological aspects of pulmonary complications of cirrhosis. Scand J Gastroenterol 2007; 42: 419–27
   PubMed Web of Science ®Google Scholar
• Moller S., Bendtsen F., Henriksen J. H. Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand J Clin Lab Invest 2001; 61: 421–9
   PubMed Web of Science ®Google Scholar
• La V. G., Laffi G., Gentilini P. Atrial natriuretic peptide and other natriuretic factors in cirrhosis. Ascites and renal dysfunction in liver disease, V Arroyo, P Gines, J Rodes, R. W Schrier. Blackwell, Malden 1999; 231–48
   Google Scholar